Cite
MLA Citation
Domingo Barber et al.. “GRAZAX®: a sublingual immunotherapy vaccine for Hay fever treatment: from concept to commercialization.” Human vaccines & immunotherapeutics, vol. 15, no. 12, 2019, pp. 2887–2895. http://access.bl.uk/ark:/81055/vdc_100101545993.0x000015